LENZ Therapeutics (LENZ) Earnings Date & Reports

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LENZ is expected to report earnings to fall 24.99% to -99 cents per share on November 11

LENZ Therapeutics LENZ Stock Earnings Reports

Q3'26

Est.

$-0.99

Q1'26

Missed

by $0.15

Q4'25

Missed

by $0.40

Q3'25

Missed

by $0.19

Q2'25

Beat

by $0.08

The last earnings report on May 11 showed earnings per share of -132 cents, missing the estimate of -116 cents. With 211.57K shares outstanding, the current market capitalization sits at 183.65M.

View a ticker or compare two or three

LENZ

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days